WallStreetZenWallStreetZen

NYSE: MDT
Medtronic PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MDT past earnings growth

How has MDT's earnings growth performed historically?
Company
-16.44%
Industry
5.8%
Market
14.26%
MDT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MDT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MDT's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MDT past revenue growth

How has MDT's revenue growth performed historically?
Company
-3.19%
Industry
5.46%
Market
13.91%
MDT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MDT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MDT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MDT earnings and revenue history

Current Revenue
$30.8B
Current Earnings
$4.1B
Current Profit Margin
13.2%
MDT's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

MDT Return on Equity

Current Company
7.8%
Current Industry
8.3%
Current Market
188%
MDT's Return on Equity (7.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MDT announces earnings.

MDT Return on Assets

Current Company
4.4%
Current Industry
4.8%
MDT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MDT Return on Capital Employed

Current Company
7.5%
Current Industry
8.4%
MDT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MDT vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MDT$30.77B$8.69B$4.06B+0.69%+8.16%
SYK$18.95B$3.35B$2.63B+8.28%+20.57%
BSX$13.05B$2.83B$846.00M+7.08%+45.65%
EW$5.50B$1.91B$1.49B+9.80%+22.13%
ABT$41.51B$10.82B$5.80B+7.85%+66.33%
View Top Medical Device Stocks

Medtronic Earnings & Revenue FAQ

What were MDT's earnings last quarter?

On Invalid Date, Medtronic (NYSE: MDT) reported Q4 2022 earnings per share (EPS) of $0.92, up 16.36% year over year. Total Medtronic earnings for the quarter were $1.22 billion. In the same quarter last year, Medtronic's earnings per share (EPS) was $1.10.

If you're new to stock investing, here's how to buy Medtronic stock.

What was MDT's earnings growth in the past year?

As of Q2 2023, Medtronic's earnings has grown -16.44% year over year. This is 22.23 percentage points lower than the US Medical Devices industry earnings growth rate of 5.8%. Medtronic's earnings in the past year totalled $4.06 billion.

What was MDT's revenue last quarter?

On Invalid Date, Medtronic (NYSE: MDT) reported Q4 2022 revenue of $7.73 billion up 0.46% year over year. In the same quarter last year, Medtronic's revenue was $7.76 billion.

What was MDT's revenue growth in the past year?

As of Q2 2023, Medtronic's revenue has grown -3.19% year over year. This is 8.65 percentage points lower than the US Medical Devices industry revenue growth rate of 5.46%. Medtronic's revenue in the past year totalled $30.77 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.